To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects with Stable Coronary Artery Disease

Trial Identifier: D5780C00002
Sponsor: MedImmune, LLC
NCTID:: NCT02601560
Start Date: December 2015
Primary Completion Date: August 2016
Study Completion Date: November 2016
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, AL Anniston, AL, United States of America, 36207
United States of America, FL Jacksonville, FL, United States of America, 32216
United States of America, FL Port Orange, FL, United States of America, 32127
United States of America, NC Durham, NC, United States of America, 27710
United States of America, NC Raleigh, NC, United States of America, 27612
United States of America, OH Cincinnati, OH, United States of America, 45227
United States of America, TX San Antonio, TX, United States of America, 78229
United States of America, VA Falls Church, VA, United States of America, 22042